St. Louis Heart and Vascular

St Louis, Missouri 63136

3 studies enrolling now · 28 studies all time

What they study most

Acute Coronary Syndrome, Acute Coronary Syndromes, Arrhythmias, Cardiac, Atherosclerosis, Atherosclerotic Cardiovascular Disease, Atrial Fibrillation, CCM Therapy, CRT-D Cardiac Resynchronization Therapy Defibrillator, Cardiac Resynchronization Therapy, Cardiovascular Diseases, Congestive Heart Failure, Coronary Artery Disease

Studies at this site

• Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction — Recruiting now
• SELUTION 4 De Novo Small Vessel IDE Trial — Recruiting now
• The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR — Recruiting now
• Endovascular Ablation of the Right Greater Splanchnic Nerve in Subjects Having HFpEF — Recruiting now
• A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients. — Running, not enrolling
• Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease — Running, not enrolling
• A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation — Running, not enrolling
• Assessment of Combined CCM and ICD Device in HFrEF — Running, not enrolling
• Baroreflex Activation Therapy for Heart Failure — Completed
• Management of LDL-cholesterol With Inclisiran + Usual Care Compared to Usual Care Alone in Participants With a Recent Acute Coronary Syndrome — Completed
• Heart Failure Optimization Study — Completed
• Benefits of Microcor in Ambulatory Decompensated Heart Failure — Completed
• C-Pulse® System: A Heart Assist Device Clinical Study — Stopped early
• Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation — Completed
• Avoiding Treatment in the Hospital With Furoscix for the Management of Congestion in Heart Failure - A Pilot Study — Completed
• BIO monitorinG in Patients With Preserved Left ventricUlar Function AfteR Diagnosed Myocardial Infarction — Completed
• REDUCE LAP-HF TRIAL II — Running, not enrolling
• LONGEVITY Study. Evaluation of the Device and Battery Longevity of Boston Scientific Market-released ICD and CRT-D Devices — Completed
• Assessment of the Utility of BIOMONITOR to Identify Atrial Fibrillation (AF) in Ablation Candidates Using Precise AF Detection — Stopped early
• Study to Evaluate Effects of INL1 in Patients With Heart Failure and Reduced Ejection Fraction — Status unconfirmed
• QP ExCELs: MultiPole Pacing (MPP) Sub-Study — Completed
• Plexa ICD Lead Registry — Stopped early
• A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart — Completed
• Safety and Effectiveness of B-Laser™ in Subjects Affected With Infrainguinal PAD — Completed
• PLATINUM Diversity — Completed
• Sensible Medical Innovations Lung fLuid Status Monitor Allows rEducing Readmission Rate of Heart Failure Patients — Stopped early
• INcrease Of VAgal TonE in CHF — Stopped early
• TRIAGE-CRT Telemonitoring in Patients With CHF and Indication of CRT-D — Completed